Award
NIH Reporter #5R01AI174540-03
A role for pharmaceutical control of protease-activated receptor-2 for the treatment of asthma
Recipient
National Institute of Allergy and Infectious Diseases (NIAID)
Award Amount
$761,371.00
Ceiling
$761,371.00
Awarded
June 01, 2026
Identifier
5R01AI174540-03
NIH funded research project to study the pharmaceutical control of protease-activated receptor-2 for asthma treatment, with a total award amount of $761,371 for fiscal year 2026.
Description
The project involves research on asthma, focusing on the role of protease-activated receptor-2 (PAR2) and developing novel therapeutics. The project aims to specify pharmacological impact of PAR2 modulation on airway epithelial cells and sensory neurons in vitro and in pre-clinical asthma models.